Lenacapavir: a first-in-class capsid inhibitor for HIV treatment and prevention
{{output}}
Purpose of review: This review summarizes available data for lenacapavir (LEN), a first-in-class agent that targets several functions of the HIV capsid in the viral cycle, including nuclear entry, viral assembly, and capsid forma... ...
